Journal of Affective Disorders
Volume 121, Issue 1 , Pages 143-146 , February 2010

Onset-age of bipolar disorders at six international sites

  • R.J. Baldessarini

      Affiliations

    • Department of Psychiatry & Neuroscience Program, Harvard Medical School, USA
    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Corresponding Author InformationCorresponding author. Mailman Research Center, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA.
    • ,
  • L. Bolzani

      Affiliations

    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Department of Psychiatry, Viarnetto Psychiatric Clinic, Lugano, Switzerland
    • Department of Psychiatry, University of Cagliari; Lucio Bini Mood Disorder Center, Cagliari, Sardinia, Italy
    • ,
  • N. Cruz

      Affiliations

    • Department of Psychiatry & Neuroscience Program, Harvard Medical School, USA
    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Bipolar Disorders Program, Institute of Clinical Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Spain
    • ,
  • P.B. Jones

      Affiliations

    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Bipolar Disorders Program, Institute of Clinical Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Spain
    • ,
  • M. Lai

      Affiliations

    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Department of Psychiatry, Viarnetto Psychiatric Clinic, Lugano, Switzerland
    • Department of Psychiatry, University of Cagliari; Lucio Bini Mood Disorder Center, Cagliari, Sardinia, Italy
    • ,
  • B. Lepri

      Affiliations

    • Department of Psychiatry, Viarnetto Psychiatric Clinic, Lugano, Switzerland
    • Department of Psychiatry, University of Cagliari; Lucio Bini Mood Disorder Center, Cagliari, Sardinia, Italy
    • ,
  • J. Perez

      Affiliations

    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • CAMEO Early Intervention Services, Department of Psychiatry, University of Cambridge, UK
    • ,
  • P. Salvatore

      Affiliations

    • Department of Psychiatry & Neuroscience Program, Harvard Medical School, USA
    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Department of Neuroscience, Section of Psychiatry, University of Parma, Italy
    • ,
  • M. Tohen

      Affiliations

    • Department of Psychiatry & Neuroscience Program, Harvard Medical School, USA
    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Department of Psychiatry, University of Texas, San Antonio, TX, United States
    • ,
  • L. Tondo

      Affiliations

    • Department of Psychiatry & Neuroscience Program, Harvard Medical School, USA
    • Department of Psychiatry, Viarnetto Psychiatric Clinic, Lugano, Switzerland
    • Department of Psychiatry, University of Cagliari; Lucio Bini Mood Disorder Center, Cagliari, Sardinia, Italy
    • ,
  • E. Vieta

      Affiliations

    • International Consortium for Bipolar Disorder Research, McLean Division of Massachusetts General Hospital, Belmont, MA, USA
    • Bipolar Disorders Program, Institute of Clinical Neuroscience, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Spain

Received 6 February 2009 ,Revised 27 May 2009 ,Accepted 28 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclosures: Dr. Baldessarini has recently been a consultant or investigator-initiated research collaborator with: AstraZeneca, Auritec, Biotrofix, Janssen, JDS-Noven, Lilly, Luitpold, NeuroHealing, Novartis, Pfizer, and SK-BioPharmaceutical Corporation; he is not a member of pharmaceutical speakers' bureaus, nor does he or any family member hold equity positions in biomedical or pharmaceutical corporations. Dr. Perez is a former employee of Eli Lilly Corporation (to 2004). Dr. Tohen was an employee of Eli Lilly & Co (to 2008), and is a consultant or has received speaker's honoraria from Astra-Zeneca, BristolMyers-Squibb, Eli Lilly, Glaxo-SmithKline, Johnson & Johnson and Wyeth Corporations; his spouse is an Eli Lilly employee and stockholder. Dr. Vieta has served as a consultant or speaker for Astra-Zeneca, BristolMyers-Squibb, Eli Lilly, Forest Research Institute, Glaxo-Smith-Kline, Janssen-Cilag, Jazz, Lundbeck, Merck, Novartis, Organon, Otsuka, Pfizer, Sanofi-Aventis, Servier, Shering-Plough, United Biosource, and Wyeth Corporations. Other authors have no relevant disclosures of potential conflicts of interest.

PII: S0165-0327(09)00253-5

doi: 10.1016/j.jad.2009.05.030

Journal of Affective Disorders
Volume 121, Issue 1 , Pages 143-146 , February 2010

Article Tools

* Image Usage & Resolution